Clinical Trials Logo

Anxiety Disorders clinical trials

View clinical trials related to Anxiety Disorders.

Filter by:

NCT ID: NCT00190879 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

Start date: June 2005
Phase: Phase 4
Study type: Interventional

To investigate the effect of atomoxetine hydrochloride in treating adults who have attention deficit hyperactivity disorder with comorbid social anxiety disorder

NCT ID: NCT00183274 Completed - Anxiety Disorders Clinical Trials

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

Start date: January 2004
Phase: Phase 4
Study type: Interventional

This study will assess the effectiveness of venlafaxine XR in preventing the relapse of generalized anxiety disorder after 6 months of treatment versus 12 months of treatment.

NCT ID: NCT00182533 Terminated - Clinical trials for Major Depressive Disorder

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Start date: July 2002
Phase: Phase 4
Study type: Interventional

Selective serotonin reuptake inhibitors (SSRIs) including sertraline have been found to be effective in the treatment of generalized social phobia (GSP). However, virtually all of the current treatment studies with medicines, including the SSRIs, have excluded patients with social phobia who have other co-occurring conditions. In fact, 80% of individuals suffering with primary social phobia have at least one other anxiety. This study will evaluate the safety and efficacy of sertraline in the treatment of generalized social phobia with co-occurring anxiety and mood disorders.

NCT ID: NCT00178022 Completed - Depression Clinical Trials

A Trial of Two On-Line Interventions for Child Brain Injury

Start date: February 2005
Phase: N/A
Study type: Interventional

The primary aims of this project are to examine the feasibility and relative efficacy of two models of on-line intervention for families of children with traumatic brain injury: one, a model emphasizing cognitive appraisals and problem solving skills; the other, emphasizing linking families to resources and providing professionally-moderated peer support.

NCT ID: NCT00177008 Completed - Schizophrenia Clinical Trials

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Start date: March 2004
Phase: Phase 4
Study type: Interventional

This study will determine the efficacy of a medication switch to Aripiprazole for the treatment of schizophrenia or schizoaffective disorder in patients with moderate to high symptoms of social anxiety. Specifically the study will test the possibility that a medication switch to Aripiprazole reduces symptoms of social anxiety in this patient population.

NCT ID: NCT00176670 Completed - Anxiety Clinical Trials

A GameBoy as a Distraction Before Surgery in Children

Start date: January 2004
Phase: Phase 2
Study type: Interventional

Preoperative anxiety is characterized by subjective feelings of tension, apprehension, nervousness and worry. In children, preoperative anxiety is reported to result in postoperative negative psychological effects, including nightmares, separation anxiety, eating problems and increased fear of doctors. Anxiety in children can be expressed in many forms. Many children look scared, become agitated, breathe deeply, tremble, and stop talking or playing and start to cry. They may unexpectedly urinate or may actively attempt to escape from the medical personnel. These reactions reflect the child's fear of separation from the parents, as well as loss of control, unfamiliar routines, instruments and hospital procedures [1]. Previous studies have assessed anxiety in children during the preoperative period and the effects of premedication and parental presence during induction of anesthesia (PPIA) [2]. Midazolam has been proven to reduce preoperative anxiety in children [3]. Side effects related to oral midazolam administered to healthy children are minimal and the drug can be reversed with flumazenil but post operative recovery may be delayed in those children undergoing a short surgical procedure. It is the experience of the investigator that there are some children who have such low levels of anxiety they do not require any intervention Distraction may be particularly helpful in children ages 6-12 as these children may not receive preoperative medication due to their curiosity about the environment. Previous studies regarding distraction therapy have focused on the parent either blowing bubbles or reading to a child [4]. Studies where the child is actively engaged in a distraction activity have not been documented. The purpose of this investigation is to determine whether in the presence of a parent an interactive distraction intervention, i.e. Game Boy which is a hand held video game, is as effective as preoperative Midazolam in reducing preoperative anxiety. This study may help in the search for a low cost and easy to implement method of reducing anxiety for children undergoing surgery.

NCT ID: NCT00167479 Completed - Bipolar Disorder Clinical Trials

A Study of Risperidone Monotherapy in Bipolar Anxiety

Start date: September 2003
Phase: Phase 4
Study type: Interventional

The specific aim of this study is to evaluate the efficacy, tolerability, and safety of risperidone monotherapy in the treatment of ambulatory bipolar disorder with comorbid lifetime panic disorder or generalized anxiety disorder and current at least moderately severe anxiety.

NCT ID: NCT00164203 Completed - Depression Clinical Trials

The Feelings Club: Evaluating a School-based Intervention for Children at Risk for Depression and Anxiety Disorders

Start date: April 2005
Phase: N/A
Study type: Interventional

Anxiety and mood disorders are among the most prevalent mental health problems in childhood. They have severe long-term morbidity, and associated academic and social impairment. Building on the investigators' experience with outcome evaluation in clinically anxious or depressed children, they propose to evaluate within the school system a cognitive behavioral therapy (CBT) intervention for children in grades 3 to 6 with elevated symptoms of anxiety or depression on standardized questionnaires. The participant's outcomes will be compared with those of similar children randomly assigned to an activity control group. Hypothesis 1a): Children in the intervention condition will show greater symptom reduction relative to children in the control condition (primary outcome: anxiety symptoms). Hypothesis 1b): Children in the intervention condition will show fewer symptoms during follow-up relative to children in the control condition. Hypothesis 2: Children with anxious or depressive symptoms treated in the school setting using CBT have a lower risk of developing internalizing disorders within 1 year of treatment than children in a control condition. Hypothesis 3: Self-esteem, anxiety and depression-related impairment, and academic functioning will improve more in intervention participants than in controls. Hypothesis 4: School characteristics, child age, and attitudes of participating personnel are predictive of treatment response.

NCT ID: NCT00163865 Completed - Anxiety Disorders Clinical Trials

A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents

Start date: May 2005
Phase: N/A
Study type: Observational

The aim of the following pilot study is to examine boredom in a community sample of adolescents and a clinical sample of adolescents. This is important in order to examine differences among healthy adolescents and adolescents with mental illness.

NCT ID: NCT00158327 Completed - Anxiety Disorders Clinical Trials

Telephone-Based Care Management Program for Individuals With Anxiety Disorders

Start date: March 2004
Phase: Phase 3
Study type: Interventional

This study will determine the impact of a telephone-based care management program for primary care patients with panic disorder or generalized anxiety disorder.